Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9623026
APP PUB NO 20160243119A1
SERIAL NO

15146164

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a compound of formula (I)

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • CEPHALON, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Allwein, Shawn P Downingtown, US 9 22
Courvoisier, Laurent Thorndale, US 22 78
Jacobs, Martin J Versailles, US 27 129
Ott, Gregory R Media, US 33 156

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 18, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00